Tiziana Life Sciences plc, of London, raised gross proceeds of about £3.42 million (US$4.8 million) from its now-closed underwritten, registered public offering of 442,910 American depositary shares (ADSs). The company granted its sole bookrunner, Laidlaw & Co. Ltd., a 30-day option to purchase up to an additional 66,437 ADSs.